Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.820
-0.110 (-3.75%)
At close: Sep 9, 2026, 4:00 PM EDT
2.818
-0.002 (-0.07%)
Pre-market: Sep 10, 2026, 7:30 AM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $229.38 million as of September 9, 2026. Its market cap has increased by 48.19% in one year.
Market Cap
229.38M
Enterprise Value
141.09M
1-Year Change
48.19%
Ranking
Category
Stock Price
$2.82
ChartMarket Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $229.38M, an increase of 413.62%. That is a compound annual growth rate of 19.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 229.38M | 102.14% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 235.42M |
| Invivyd | 235.01M |
| Compugen | 234.92M |
| Cellectis | 231.49M |
| NervGen Pharma | 229.02M |
| Sol-Gel Technologies | 226.50M |
| Protara Therapeutics | 226.34M |
| Neumora Therapeutics | 225.48M |